Metformin-Clinical Pharmacology in PCOs

Oligo-anovulation, hyperandrogenism and insulin resistance characterizes polycystic ovary syndrome (PCOs). Metformin is the oldest insulin sensitizer used in the management of type 2 diabetes mellitus. In PCOs, metformin decreases the serum lipids, androgen and insulin; induces ovulation and regular...

Descripción completa

Detalles Bibliográficos
Autores principales: Dumitrescu, R, Mehedintu, C, Briceag, I, Purcărea, VL, Hudita, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2015
Materias:
General Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392089/
https://www.ncbi.nlm.nih.gov/pubmed/25866577
_version_ 1782365921172520960
author Dumitrescu, R
Mehedintu, C
Briceag, I
Purcărea, VL
Hudita, D
author_facet Dumitrescu, R
Mehedintu, C
Briceag, I
Purcărea, VL
Hudita, D
author_sort Dumitrescu, R
collection PubMed
description Oligo-anovulation, hyperandrogenism and insulin resistance characterizes polycystic ovary syndrome (PCOs). Metformin is the oldest insulin sensitizer used in the management of type 2 diabetes mellitus. In PCOs, metformin decreases the serum lipids, androgen and insulin; induces ovulation and regular menstrual cycle; increases the pregnancy rate.
format Online
Article
Text
id pubmed-4392089
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Carol Davila University Press
record_format MEDLINE/PubMed
spelling pubmed-43920892015-06-01 Metformin-Clinical Pharmacology in PCOs Dumitrescu, R Mehedintu, C Briceag, I Purcărea, VL Hudita, D J Med Life General Articles Oligo-anovulation, hyperandrogenism and insulin resistance characterizes polycystic ovary syndrome (PCOs). Metformin is the oldest insulin sensitizer used in the management of type 2 diabetes mellitus. In PCOs, metformin decreases the serum lipids, androgen and insulin; induces ovulation and regular menstrual cycle; increases the pregnancy rate. Carol Davila University Press 2015 /pmc/articles/PMC4392089/ /pubmed/25866577 Text en ©Carol Davila University Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle General Articles
Dumitrescu, R
Mehedintu, C
Briceag, I
Purcărea, VL
Hudita, D
Metformin-Clinical Pharmacology in PCOs
title Metformin-Clinical Pharmacology in PCOs
title_full Metformin-Clinical Pharmacology in PCOs
title_fullStr Metformin-Clinical Pharmacology in PCOs
title_full_unstemmed Metformin-Clinical Pharmacology in PCOs
title_short Metformin-Clinical Pharmacology in PCOs
title_sort metformin-clinical pharmacology in pcos
topic General Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392089/
https://www.ncbi.nlm.nih.gov/pubmed/25866577
work_keys_str_mv AT dumitrescur metforminclinicalpharmacologyinpcos
AT mehedintuc metforminclinicalpharmacologyinpcos
AT briceagi metforminclinicalpharmacologyinpcos
AT purcareavl metforminclinicalpharmacologyinpcos
AT huditad metforminclinicalpharmacologyinpcos

Ejemplares similares